The rollout of lateral flow tests across campuses has slipped off the radar. How is it working, and what lessons can be learnt, asks Gareth Iacobucci
The costly rollout of screening for covid-19 among asymptomatic students at UK universities has found very few positive cases since its launch in December, an investigation by The BMJ has found.
Its research shows a mass testing system across UK campuses that is inconsistent and shrouded in secrecy. Almost two thirds of higher education institutions are not collecting data on numbers of students being tested, and a third are not logging how many test positive.
Experts have described campus testing as haphazard and messy, with an “outrageous” price tag. One said that the scheme was putting political ambitions above the goals of science or health.